SCHEMBL24185293

SCHEMBL24185293

O=C(c1cnc(Cl)cn1)N1CC[C@@H](F)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT6 Q8N6T7 1/20 0.44
ALDH1A1 P00352 3/20 0.41
HPGD P15428 1/20 0.41
LMNA P02545 1/20 0.41
SCN9A Q15858 8/20 0.40
SCN10A Q9Y5Y9 3/20 0.39
SCN7A Q01118 2/20 0.39
KCNH2 Q12809 2/20 0.39
SCN5A Q14524 2/20 0.39
SCN8A Q9UQD0 1/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CCNK O75909 1/20 0.39
CDK12 Q9NYV4 1/20 0.39
DPP4 P27487 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24114345 0.78 SCN9A (0.40) HPGDSCN9ASCN10ASCN7AKCNH2
SCHEMBL22400785 0.78 SCN9A (0.40) HPGDSCN9ASCN10ASCN7AKCNH2
SCHEMBL24185773 0.78 HPGD (0.53) HPGDCCNKCDK12L3MBTL3L3MBTL1
SCHEMBL24185283 0.78 HPGD (0.53) HPGDCCNKCDK12L3MBTL3L3MBTL1
SCHEMBL320648 0.78 SIRT6 (0.52) SIRT6ALDH1A1HPGDLMNAMEN1
SCHEMBL1725086 0.78 SIRT6 (0.52) SIRT6ALDH1A1HPGDPOLBMEN1
SCHEMBL16973635 0.76 PRKAA2 (0.44) SIRT6MEN1KMT2ATDP1CCNK
SCHEMBL24185769 0.75 ALDH1A1 (0.46) ALDH1A1HPGDSCN9ASCN10ASCN7A
SCHEMBL424331 0.74 POLB (0.49) SIRT6ALDH1A1HPGDLMNAPOLB
SCHEMBL1722269 0.74 SMN1; SMN2 (0.59) SIRT6ALDH1A1HPGDMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230373985-A1 KINASE MODULATORS AND METHODS OF USE THEREOF ORIGENIS GMBH (DE) 2023-11-23 US disclosed
US-20230373985-A1 KINASE MODULATORS AND METHODS OF USE THEREOF ORIGENIS GMBH (DE) 2023-11-23 US disclosed
WO-2022011337-A1 KINASE MODULATORS AND METHODS OF USE THEREOF ORIGENIS GMBH (DE) 2022-01-13 WO disclosed
WO-2022011338-A2 KINASE MODULATORS AND METHODS OF USE THEREOF ORIGENIS GMBH (DE) 2022-01-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230373985-A1 KINASE MODULATORS AND METHODS OF USE THEREOF TYK2, MAPKAPK2, MAP3K20 SIRT6 1474/4885ALDH1A1 4878/4885HPGD 4226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.